Site Logo

Designed for breakthroughs.

Australia’s newest home for biotech innovation is taking shape. Be one of the first to take part.

Find out more

In Partnership With

In conjunction with SEQ City Deal Partner
media

Frequently asked questions

What is the Industry Biotechnology Centre?

The Industry Biotechnology Centre (IBC) is Australia’s first vertically integrated biotechnology facility, located within the AATLIS Innovation Precinct in Toowoomba. It supports the rapid design, building, testing and manufacturing of biotech solutions that address major challenges in industry, agriculture and the environment.

The centre brings together cutting-edge technologies such as AI, machine learning, and Level 4 bioreactors to drive collaborative innovation from idea to market.

What technology will be available at the IBC?

Step into the future of biotechnology at the IBC – where discovery meets scale. Purpose-built to accelerate breakthroughs, the facility will integrate cutting-edge PC2 and PC3 laboratories, advanced manufacturing zones, and commercial office spaces into a single ecosystem designed for innovation.

At the core of the IBC will be transformative technologies like Liina AI, revolutionising molecular discovery with unprecedented precision, and our Industry 6.0 bioreactor, engineered for high-efficiency biomass extrapolation and scalable production.

This is more than infrastructure – it’s a launchpad for biotech pioneers ready to shape the next era of agriculture, environmental, and industrial biology. 

Where will the centre be located?

The IBC will be based in the FKG Group’s AATLIS Precinct in Wellcamp on the outskirts of Toowoomba. The location is located within the Charlton Wellcamp Industrial Area and part of the Toowoomba Enterprise Hub.

The region is strategically positioned to support biotech innovation with access to transport, industry partners, and skilled talent.

Who is involved in the IBC?

The IBC is powered by a growing network of global industry partners, government support, and innovation experts. Key contributors include:

AATLIS Precinct Developer and Infrastructure Leadership:

Biotechnology R&D and validation:

Market engagement and commercialisation:

Additional partners will be announced as the centre progresses.

When will the centre open?

Construction and operational planning are underway with the following milestones:

  • Mid–Late 2026 – Stage 1 construction begins
  • 2027 – Completion and commissioning of core facilities
  • 2028 – Expansion of R&D and logistics capabilities

Who is the Centre for?

The IBC is designed for:

  • Industry leaders in agtech, biomanufacturing, and environmental solutions
  • Researchers and developers seeking advanced R&D infrastructure
  • Startups and scale-ups looking to bring new biotech to market
  • Government and commercial entities driving innovation agendas

If you’re solving real-world problems with biotech — this is the place for you.

How can I get involved?

There are many ways to engage with the IBC:

  • Partner on R&D and commercialisation projects
  • Lease space for biotech production or testing
  • Join our innovation programs or pilot trials
  • Connect with Go2Market Pro or Bio10 for development and market access support

Reach out to our team to start a conversation or explore collaboration options.

How do I enquire about tenancy or leasing space at the IBC?

For tenancy enquiries, please contact:

Markus Eames, Transactions Manager – FKG Group

[email protected]

0407 388 856

Grant Statton, CEO AATLIS – FKG Group

[email protected]

0439 200 523

Case Study

Explore how a multi-partner collaboration within the Industry Biotechnology Centre fast tracked the development of a next gen bioprocessing platform.

By combining academic research, advanced analytics, and commercial prototyping, the project team was able to reduce development time, improve process stability, and move from bench to pilot scale in under 12 months.

Download Case Study PDF
image-0

The planned Industry Biotechnology Centre (Artist’s Impression Only).

image-1

The planned Industry Biotechnology Centre (Artist’s Impression Only).

image-2

The planned Industry Biotechnology Centre (Artist’s Impression Only).

image-3

The planned Industry Biotechnology Centre (Artist’s Impression Only).

image-4

The planned Industry Biotechnology Centre (Artist’s Impression Only).

Opportunity Statement

Discover the full vision behind the Industry Biotechnology Centre. Enter your details to access the Opportunity Statement and explore what’s ahead.

Enter your details to view
icon

Fill in your details below to view our Opportunity Statement.

Latest News

Catch up on the latest news

RENDERS AND IMAGERY DISCLAIMER:
Please note: The images displayed of the planned Industry Biotechnology Centre (IBC) are artist’s impressions only and have been produced for general information purposes only. The images have been created prior to planning and statutory approvals being obtained, and construction being commenced. Please note that these images, along with any interior and exterior impressions (including landscaping) and finishes, are intended as a general guide only and may differ from the final product. Changes may occur during the development process due to various factors including design changes, planning and statutory approvals, market conditions, construction conditions, finance conditions and other legislative requirements, and the final outcome may vary.

GENERAL DISCLAIMER:
Please note: The information, statements and images contained in this website have been produced as a general guide only and does not form part of any offer to lease within the proposed Industry Biotechnology Centre. The Website content was produced prior to completion of the development and is subject to changes that may occur as the development progresses. While this website reflects the proposed development as at 05/08/2025, it is intended for information purposes only and is subject to changes that may occur as the development progresses due to various factors including design changes, planning and statutory approvals, market conditions, construction conditions, finance conditions, grant and government funding and other legislative requirements.

Changes to the development may be made by the Developer and may include but are not limited to the plans, specifications, fixtures and fittings, colour schemes and facilities and services offered. The artists’ impressions of the proposed Industry Biotechnology Centre depicting any interior and exterior impressions (including landscaping) have been produced for general information purposes, are indicative only and the final outcome may differ from those depicted in this website or any marketing material. The finishes materials are indicative only and are subject to the Developer’s right to make variations and substitutions. Maps are not to scale. Floorplan areas, tenancy configurations and all dimensions are indicative only, pending surveyor advice and are subject to change without notice. Any images containing fit-out, furnishings and equipment are indicative only and are not included in any offer to lease. All tenancies are subject to the terms of the offer to lease and subsequent agreement for lease and lease. Potential tenants must rely on their own enquiries and inspections and consult the Leasing Information Memorandum for further details.  The Developer makes no warranties (express or implied) as to the accuracy of the information, statements and images contained in this website or any marketing material. The FKG Group and its associated entities expressly exclude any and all liability relating to, or resulting from, the use of or reliance on, any information contained on this website by any person. 

Read More